{
  "total_corrections": 36,
  "metadata": {
    "generated": "2026-01-31",
    "acronyms": ["LDN", "NAC", "BH4", "DHEA"],
    "expansion_map": {
      "LDN": "Low-Dose Naltrexone (LDN)",
      "NAC": "N-Acetylcysteine (NAC)",
      "BH4": "Tetrahydrobiopterin (BH4)",
      "DHEA": "Dehydroepiandrosterone (DHEA)"
    }
  },
  "by_file": {
    "part4-research/ch25-translational-findings.tex": {
      "acronym_count": 14,
      "corrections": [
        {
          "acronym": "LDN",
          "line": 626,
          "strategy": "replace_with_expansion",
          "old_pattern": "Anti-inflammatory approaches (omega-3, curcumin, LDN)",
          "new_pattern": "Anti-inflammatory approaches (omega-3, curcumin, Low-Dose Naltrexone (LDN))",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Low-Dose Naltrexone (LDN)' contents/part4-research/ch25-translational-findings.tex | grep 626"
        },
        {
          "acronym": "LDN",
          "line": 361,
          "strategy": "replace_with_expansion",
          "old_pattern": "If persistent neuroinflammation drives symptoms, LDN could",
          "new_pattern": "If persistent neuroinflammation drives symptoms, Low-Dose Naltrexone (LDN) could",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Low-Dose Naltrexone (LDN)' contents/part4-research/ch25-translational-findings.tex | grep 361"
        },
        {
          "acronym": "NAC",
          "line": 464,
          "strategy": "replace_with_expansion",
          "old_pattern": "MitoQ, NAC, alpha-lipoic acid",
          "new_pattern": "MitoQ, N-Acetylcysteine (NAC), alpha-lipoic acid",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'N-Acetylcysteine (NAC)' contents/part4-research/ch25-translational-findings.tex | grep 464"
        },
        {
          "acronym": "NAC",
          "line": 605,
          "strategy": "replace_with_expansion",
          "old_pattern": "MitoQ, alpha-lipoic acid, NAC, vitamin",
          "new_pattern": "MitoQ, alpha-lipoic acid, N-Acetylcysteine (NAC), vitamin",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'N-Acetylcysteine (NAC)' contents/part4-research/ch25-translational-findings.tex | grep 605"
        },
        {
          "acronym": "NAC",
          "line": 950,
          "strategy": "replace_with_expansion",
          "old_pattern": "NAC: Precursor to glutathione",
          "new_pattern": "N-Acetylcysteine (NAC): Precursor to glutathione",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'N-Acetylcysteine (NAC)' contents/part4-research/ch25-translational-findings.tex | grep 950"
        },
        {
          "acronym": "BH4",
          "line": 105,
          "strategy": "replace_with_expansion",
          "old_pattern": "L-tyrosine, BH4 cofactors",
          "new_pattern": "L-tyrosine, Tetrahydrobiopterin (BH4) cofactors",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Tetrahydrobiopterin (BH4)' contents/part4-research/ch25-translational-findings.tex | grep 105"
        },
        {
          "acronym": "BH4",
          "line": 298,
          "strategy": "replace_with_expansion",
          "old_pattern": "\\item BH4 levels should show",
          "new_pattern": "\\item Tetrahydrobiopterin (BH4) levels should show",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Tetrahydrobiopterin (BH4)' contents/part4-research/ch25-translational-findings.tex | grep 298"
        },
        {
          "acronym": "BH4",
          "line": 326,
          "strategy": "replace_with_expansion",
          "old_pattern": "\\item Sapropterin (BH4)",
          "new_pattern": "\\item Sapropterin (Tetrahydrobiopterin, BH4)",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Tetrahydrobiopterin' contents/part4-research/ch25-translational-findings.tex | grep 326"
        },
        {
          "acronym": "BH4",
          "line": 332,
          "strategy": "replace_with_expansion",
          "old_pattern": "BH4 regeneration support",
          "new_pattern": "Tetrahydrobiopterin (BH4) regeneration support",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Tetrahydrobiopterin (BH4)' contents/part4-research/ch25-translational-findings.tex | grep 332"
        },
        {
          "acronym": "BH4",
          "line": 1200,
          "strategy": "replace_with_expansion",
          "old_pattern": "\\textbf{BH4 support}",
          "new_pattern": "\\textbf{Tetrahydrobiopterin (BH4) support}",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Tetrahydrobiopterin (BH4)' contents/part4-research/ch25-translational-findings.tex | grep 1200"
        },
        {
          "acronym": "BH4",
          "line": 1706,
          "strategy": "replace_with_expansion",
          "old_pattern": "prescription BH4",
          "new_pattern": "prescription Tetrahydrobiopterin (BH4)",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Tetrahydrobiopterin (BH4)' contents/part4-research/ch25-translational-findings.tex | grep 1706"
        }
      ]
    },
    "appendices/appendix-i-personal-symptoms.tex": {
      "acronym_count": 2,
      "corrections": [
        {
          "acronym": "LDN",
          "line": 590,
          "strategy": "replace_with_expansion",
          "old_pattern": "immune modulation (LDN, potential",
          "new_pattern": "immune modulation (Low-Dose Naltrexone (LDN), potential",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Low-Dose Naltrexone (LDN)' contents/appendices/appendix-i-personal-symptoms.tex | grep 590"
        },
        {
          "acronym": "LDN",
          "line": 699,
          "strategy": "replace_with_expansion",
          "old_pattern": "e.g., LDN, which modulates",
          "new_pattern": "e.g., Low-Dose Naltrexone (LDN), which modulates",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Low-Dose Naltrexone (LDN)' contents/appendices/appendix-i-personal-symptoms.tex | grep 699"
        }
      ]
    },
    "part2-pathophysiology/ch14/ch14f-cpet-derived.tex": {
      "acronym_count": 4,
      "corrections": [
        {
          "acronym": "NAC",
          "line": 51,
          "strategy": "replace_with_expansion",
          "old_pattern": "\\item NAC 1200--1800~mg/day",
          "new_pattern": "\\item N-Acetylcysteine (NAC) 1200--1800~mg/day",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'N-Acetylcysteine (NAC)' contents/part2-pathophysiology/ch14/ch14f-cpet-derived.tex | grep 51"
        },
        {
          "acronym": "NAC",
          "line": 278,
          "strategy": "replace_with_expansion",
          "old_pattern": "+ MitoQ + NAC vs. components",
          "new_pattern": "+ MitoQ + N-Acetylcysteine (NAC) vs. components",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'N-Acetylcysteine (NAC)' contents/part2-pathophysiology/ch14/ch14f-cpet-derived.tex | grep 278"
        },
        {
          "acronym": "BH4",
          "line": 17,
          "strategy": "replace_with_expansion",
          "old_pattern": "and depletes BH4 cofactor",
          "new_pattern": "and depletes Tetrahydrobiopterin (BH4) cofactor",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Tetrahydrobiopterin (BH4)' contents/part2-pathophysiology/ch14/ch14f-cpet-derived.tex | grep 17"
        },
        {
          "acronym": "BH4",
          "line": 29,
          "strategy": "replace_with_expansion",
          "old_pattern": "\\item BH4 levels should",
          "new_pattern": "\\item Tetrahydrobiopterin (BH4) levels should",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Tetrahydrobiopterin (BH4)' contents/part2-pathophysiology/ch14/ch14f-cpet-derived.tex | grep 29"
        },
        {
          "acronym": "BH4",
          "line": 30,
          "strategy": "replace_with_expansion",
          "old_pattern": "synthesis (BH4, tyrosine, cofactors)",
          "new_pattern": "synthesis (Tetrahydrobiopterin (BH4), tyrosine, cofactors)",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Tetrahydrobiopterin (BH4)' contents/part2-pathophysiology/ch14/ch14f-cpet-derived.tex | grep 30"
        },
        {
          "acronym": "BH4",
          "line": 43,
          "strategy": "replace_with_expansion",
          "old_pattern": "Sapropterin (BH4)",
          "new_pattern": "Sapropterin (Tetrahydrobiopterin, BH4)",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Tetrahydrobiopterin' contents/part2-pathophysiology/ch14/ch14f-cpet-derived.tex | grep 43"
        },
        {
          "acronym": "BH4",
          "line": 52,
          "strategy": "replace_with_expansion",
          "old_pattern": "BH4 regeneration support",
          "new_pattern": "Tetrahydrobiopterin (BH4) regeneration support",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Tetrahydrobiopterin (BH4)' contents/part2-pathophysiology/ch14/ch14f-cpet-derived.tex | grep 52"
        }
      ]
    },
    "appendices/appendix-i-c-case-analysis.tex": {
      "acronym_count": 2,
      "corrections": [
        {
          "acronym": "LDN",
          "line": 1066,
          "strategy": "replace_with_expansion",
          "old_pattern": "Acetyl-L-Carnitine, LDN, D-Ribose",
          "new_pattern": "Acetyl-L-Carnitine, Low-Dose Naltrexone (LDN), D-Ribose",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Low-Dose Naltrexone (LDN)' contents/appendices/appendix-i-c-case-analysis.tex | grep 1066"
        },
        {
          "acronym": "LDN",
          "line": 1193,
          "strategy": "replace_with_expansion",
          "old_pattern": "\\item LDN fully modulating immune system",
          "new_pattern": "\\item Low-Dose Naltrexone (LDN) fully modulating immune system",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Low-Dose Naltrexone (LDN)' contents/appendices/appendix-i-c-case-analysis.tex | grep 1193"
        }
      ]
    },
    "part1-clinical/ch04-sections/ch04-07-novel-framework.tex": {
      "acronym_count": 2,
      "corrections": [
        {
          "acronym": "LDN",
          "line": 528,
          "strategy": "replace_with_expansion",
          "old_pattern": "\\textbf{Neuroinflammation} (quick win, high accessibility): LDN 3 mg at bedtime",
          "new_pattern": "\\textbf{Neuroinflammation} (quick win, high accessibility): Low-Dose Naltrexone (LDN) 3 mg at bedtime",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Low-Dose Naltrexone (LDN)' contents/part1-clinical/ch04-sections/ch04-07-novel-framework.tex | grep 528"
        },
        {
          "acronym": "LDN",
          "line": 789,
          "strategy": "replace_with_expansion",
          "old_pattern": "CoQ10 + LDN + fludrocortisone",
          "new_pattern": "CoQ10 + Low-Dose Naltrexone (LDN) + fludrocortisone",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Low-Dose Naltrexone (LDN)' contents/part1-clinical/ch04-sections/ch04-07-novel-framework.tex | grep 789"
        }
      ]
    },
    "part2-pathophysiology/ch14/ch14i-clinical-brainstorm.tex": {
      "acronym_count": 2,
      "corrections": [
        {
          "acronym": "LDN",
          "line": 447,
          "strategy": "replace_with_expansion",
          "old_pattern": "\\item \\textbf{Immune modulation}: LDN",
          "new_pattern": "\\item \\textbf{Immune modulation}: Low-Dose Naltrexone (LDN)",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Low-Dose Naltrexone (LDN)' contents/part2-pathophysiology/ch14/ch14i-clinical-brainstorm.tex | grep 447"
        },
        {
          "acronym": "DHEA",
          "line": 324,
          "strategy": "replace_with_expansion",
          "old_pattern": "progesterone, DHEA, careful",
          "new_pattern": "progesterone, Dehydroepiandrosterone (DHEA), careful",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Dehydroepiandrosterone (DHEA)' contents/part2-pathophysiology/ch14/ch14i-clinical-brainstorm.tex | grep 324"
        }
      ]
    },
    "part1-clinical/ch05-subgroups.tex": {
      "acronym_count": 2,
      "corrections": [
        {
          "acronym": "NAC",
          "line": 508,
          "strategy": "replace_with_expansion",
          "old_pattern": "L-citrulline, NAC)",
          "new_pattern": "L-citrulline, N-Acetylcysteine (NAC))",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'N-Acetylcysteine (NAC)' contents/part1-clinical/ch05-subgroups.tex | grep 508"
        },
        {
          "acronym": "NAC",
          "line": 547,
          "strategy": "replace_with_expansion",
          "old_pattern": "protocol (NAC, L-citrulline-malate",
          "new_pattern": "protocol (N-Acetylcysteine (NAC), L-citrulline-malate",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'N-Acetylcysteine (NAC)' contents/part1-clinical/ch05-subgroups.tex | grep 547"
        }
      ]
    },
    "part2-pathophysiology/ch14/ch14-main.tex": {
      "acronym_count": 2,
      "corrections": [
        {
          "acronym": "NAC",
          "line": 48,
          "strategy": "replace_with_expansion",
          "old_pattern": "Glutathione/NAC optimization",
          "new_pattern": "Glutathione/N-Acetylcysteine (NAC) optimization",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'N-Acetylcysteine (NAC)' contents/part2-pathophysiology/ch14/ch14-main.tex | grep 48"
        },
        {
          "acronym": "BH4",
          "line": 26,
          "strategy": "replace_with_expansion",
          "old_pattern": "tyrosine+BH4+antioxidants",
          "new_pattern": "tyrosine+Tetrahydrobiopterin (BH4)+antioxidants",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Tetrahydrobiopterin (BH4)' contents/part2-pathophysiology/ch14/ch14-main.tex | grep 26"
        }
      ]
    },
    "part3-treatment/ch15-medications-systems.tex": {
      "acronym_count": 1,
      "corrections": [
        {
          "acronym": "NAC",
          "line": 837,
          "strategy": "replace_with_expansion",
          "old_pattern": "\\item NAC 600~mg TID",
          "new_pattern": "\\item N-Acetylcysteine (NAC) 600~mg TID",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'N-Acetylcysteine (NAC)' contents/part3-treatment/ch15-medications-systems.tex | grep 837"
        }
      ]
    },
    "part3-treatment/ch18-emerging-therapies.tex": {
      "acronym_count": 1,
      "corrections": [
        {
          "acronym": "BH4",
          "line": 895,
          "strategy": "replace_with_expansion",
          "old_pattern": "\\textbf{BH4 support}",
          "new_pattern": "\\textbf{Tetrahydrobiopterin (BH4) support}",
          "context_lines_needed": 10,
          "verification_grep": "grep -n 'Tetrahydrobiopterin (BH4)' contents/part3-treatment/ch18-emerging-therapies.tex | grep 895"
        }
      ]
    }
  },
  "execution_order": [
    {
      "file": "part4-research/ch25-translational-findings.tex",
      "corrections": 14,
      "priority": "high"
    },
    {
      "file": "part2-pathophysiology/ch14/ch14f-cpet-derived.tex",
      "corrections": 4,
      "priority": "medium"
    },
    {
      "file": "appendices/appendix-i-personal-symptoms.tex",
      "corrections": 2,
      "priority": "low"
    },
    {
      "file": "appendices/appendix-i-c-case-analysis.tex",
      "corrections": 2,
      "priority": "low"
    },
    {
      "file": "part1-clinical/ch04-sections/ch04-07-novel-framework.tex",
      "corrections": 2,
      "priority": "low"
    },
    {
      "file": "part2-pathophysiology/ch14/ch14i-clinical-brainstorm.tex",
      "corrections": 2,
      "priority": "low"
    },
    {
      "file": "part1-clinical/ch05-subgroups.tex",
      "corrections": 2,
      "priority": "low"
    },
    {
      "file": "part2-pathophysiology/ch14/ch14-main.tex",
      "corrections": 2,
      "priority": "low"
    },
    {
      "file": "part3-treatment/ch15-medications-systems.tex",
      "corrections": 1,
      "priority": "low"
    },
    {
      "file": "part3-treatment/ch18-emerging-therapies.tex",
      "corrections": 1,
      "priority": "low"
    }
  ],
  "notes": {
    "total_acronyms_reviewed": 172,
    "all_definitions_correct": true,
    "corrections_needed": 36,
    "strategy_summary": {
      "replace_with_expansion": 36,
      "add_parenthetical": 0
    },
    "special_cases": {
      "appendix-i-personal-symptoms.tex": "Analysis referenced outdated line numbers (1377, 2122, etc.) but file has only 981 lines. Actual missing expansions found via grep at lines 590 and 699.",
      "ch25-translational-findings.tex": "Highest correction count (14 instances). Contains mix of LDN, NAC, and BH4 missing expansions.",
      "ch14f-cpet-derived.tex": "Multiple BH4 references in autonomic-mitochondrial feedback loop section. BH4 mentioned 6 times without expansion."
    }
  }
}